Chemotherapy Drug Shortage Causes Concern in U.S. Healthcare
The chemotherapy drug known as ifosfamide is currently experiencing a shortage in the United States. This drug is a vital…
FDA Approves Merck’s Lipfendra, First Oral PCSK9 Inhibitor
Merck has announced the FDA’s approval of its cholesterol-lowering pill Lipfendra. Notably, Lipfendra is the first oral PCSK9 inhibitor, offering…
Trump’s Election Speech Sparks Controversy Amidst New Claims
Trump’s Anticipated Election Speech President Trump is expected to deliver a primetime speech concerning the integrity of the 2020 presidential…
Employers Face Increasing Health Insurance Premiums in California
Rising Health Insurance Premiums In 2027, employers in California anticipate the highest rise in health insurance premiums in 16 years,…
Congress Moves to Make Daylight Saving Time Permanent
Congress is nearing a decision to make daylight saving time permanent in the United States, though some health experts warn…
Understanding the Threat of the New World Screwworm
The re-emergence of the New World screwworm, a parasite eradicated in the U.S. during the 1960s, has sparked concerns about…
Healthcare Price Transparency Legislation: A Step Towards Cost Efficiency
The House Energy and Commerce Committee is preparing to review a significant piece of healthcare price transparency legislation. This move…
Discoveries Through DNA Testing: The Case of Kyle Bylin and Jeremy Morrison
DNA Testing Brings Unexpected Revelations Kyle Bylin’s journey began with a simple DNA genealogy test aimed at exploring his mother’s…
Tom Brady and eMed’s Plan to Democratize Health and Wellness
Tom Brady, renowned for his illustrious career in football, has joined eMed as Chief Wellness Officer. In partnership with eMed…
Dr. Erica Schwartz’s Stance on Vaccine Policy Changes Unclear
Dr. Erica Schwartz, nominated for the role of director of the Centers for Disease Control and Prevention, participated in a…